The cookie is used to store the user consent for the cookies in the category "Performance". This cookie is set by GDPR Cookie Consent plugin. Outset Medical Patient Experience Specialist San Jose, CA Easy Apply 22d 44K-62K Per Year (Glassdoor est.) Outset Medical Clinical Project Manager San Jose, CA Easy Apply 23d 97K-144K Per Year (Glassdoor est.) Outset Medical Field Service Manager (Southeast) Atlanta, GA Easy Apply 15d 65K-105K Per Year (Glassdoor est. The cookies is used to store the user consent for the cookies in the category "Necessary". This cookie is set by GDPR Cookie Consent plugin.
The cookie is used to store the user consent for the cookies in the category "Other. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". The cookie is used to store the user consent for the cookies in the category "Analytics". These cookies ensure basic functionalities and security features of the website, anonymously. View source version on businesswire.Necessary cookies are absolutely essential for the website to function properly. Prior results do not guarantee similar outcomes. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it. The firm has recovered hundreds of millions of dollars for investors nationwide. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.īronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. If you suffered a loss in Outset you have until September 6, 2022, to request that the Court appoint you as lead plaintiff.
or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 21. Outset Medical A new way of experiencing dialysis Introducing Tabloa simple, versatile approach to reducing the cost and complexity of dialysis. If you wish to review a copy of the Complaint you can visit the firm’s site: or you may contact Peretz Bronstein, Esq. The Complaint alleges that, during the Class Period, defendants misled investors and/or failed to disclose that (1) defendants had "continuously made improvements and updates to Tablo over time since its original clearance" that required an additional 510(k) application (2) as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols (3) the Company's inability to conduct the human factors study subjected the Company to the likelihood of the FDA imposing a "shipment hold" and marketing suspension, leaving the Company unable to sell Tablo for home use and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.Ī class action lawsuit has already been filed. Such investors are encouraged to join this case by visiting the firm’s site: This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws. ("Outset" or "the Company") (NASDAQ: OM) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Outset securities between September 15, 2020, and June 13, 2022, inclusive (the “Class Period”). Attorney Advertising-Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Outset Medical, Inc.
0 kommentar(er)
